Showing results (1971-1980 of 2,018) with videos related to

Sort By:
Pageof 202
Lipids in Health and Disease|June 27, 2024
Nicotinate-curcumin improves NASH by inhibiting the AKR1B10/ACCα-mediated triglyceride synthesisXiu-Lian Lin, Ya-Ling Zeng, Jie Ning, et al.
Journal of Medicinal Chemistry|December 5, 2014
Amino acid modified xanthone derivatives: novel, highly promising membrane-active antimicrobials for multidrug-resistant Gram-positive bacterial infectionsJun-Jie Koh, Shuimu Lin, Thet Tun Aung, et al.
The Journal of Infectious Diseases|September 30, 2011
Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferretsKortney M Gustin, Taronna R Maines, Jessica A Belser, et al.
Annals of the Academy of Medicine, Singapore|January 31, 2025
Long-term survival and clinical implications of allogeneic stem cell transplantation in relapse/refractory lymphoma: A 20-year Singapore experienceWei Sheng Joshua Loke, Jean Rachel Catapia, Chay Lee Low, et al.
Hematology/Oncology and Stem Cell Therapy|April 30, 2018
Vinorelbine-Cyclophosphamide compared to cyclophosphamide in peripheral blood stem cell mobilization for multiple myelomaSanjay de Mel, Yunxin Chen, Adeline Lin, et al.
Cancer Research|March 18, 2016
Natural Product Vibsanin A Induces Differentiation of Myeloid Leukemia Cells through PKC ActivationZu-Yin Yu, He Xiao, Li-Mei Wang, et al.
Journal of Medicinal Chemistry|June 14, 2017
Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase InhibitorsTeng-Kuang Yeh, Ching-Chuan Kuo, Yue-Zhi Lee, et al.
Journal of Advanced Research|February 3, 2023
LncRNA NIPA1-SO confers atherosclerotic protection by suppressing the transmembrane protein NIPA1Min Jiang, Yu Song, Mei-Xia Ren, et al.
Journal of Advanced Research|May 24, 2021
Rare variants discovery by extensive whole-genome sequencing of the Han Chinese population in Taiwan: Applications to cardiovascular medicineJyh-Ming Jimmy Juang, Tzu-Pin Lu, Ming-Wei Su, et al.
Pharmacological Research|December 21, 2024
Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft modelsYa-Chu Tang, Jing-Jim Ou, Shu-Ching Hsu, et al.
Pageof 202